Supplementary Methods from CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

Adam Siddiqui-Jain,Denis Drygin,Nicole Streiner,Peter Chua,Fabrice Pierre, Sean E. O'Brien,Josh Bliesath,Mayuko Omori,Nanni Huser,Caroline Ho,Chris Proffitt,Michael K. Schwaebe,David M. Ryckman,William G. Rice,Kenna Anderes

crossref（2023）

引用 0|浏览1

暂无评分

摘要

Supplementary Methods from CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要